2 Sources
[1]
Proscia Launches Concentriq Embeddings and Developer Toolkit to Unleash Pathology AI Development
PHILADELPHIA, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Proscia®, a global leader in AI-enabled pathology solutions for precision medicine, today announced the launch of Concentriq® Embeddings and the Proscia AI Toolkit, enabling life sciences organizations to accelerate the discovery and development of
[2]
Proscia launches Concentriq embeddings and developer toolkit for pathology AI development
Life sciences organisations can use the tool to rapidly build AI algorithms to discover biomarkers, optimise clinical trials, and advance companion diagnostics. × Expand Ella Marushchenko Proscia, a leader in AI-enabled pathology solutions for precision medicine, has announced the launch of
Share
Copy Link
Proscia, a leader in digital and computational pathology, has launched Concentriq Embeddings and a new Developer Toolkit. These innovations aim to streamline the development and deployment of AI applications in pathology, potentially revolutionizing disease diagnosis and treatment.

Proscia, a pioneer in digital and computational pathology, has announced the release of Concentriq Embeddings and a new Developer Toolkit, marking a significant advancement in the field of pathology AI development
1
. These innovative tools are designed to accelerate the creation and implementation of AI applications in pathology, potentially transforming the landscape of disease diagnosis and treatment.Concentriq Embeddings represents a breakthrough in pathology AI development. This technology utilizes advanced machine learning techniques to convert whole slide images into compact numerical representations, known as embeddings
1
. These embeddings capture essential visual and contextual information from pathology slides, enabling AI models to process and analyze data more efficiently.The introduction of Concentriq Embeddings addresses a critical challenge in pathology AI development: the need for vast amounts of computational resources to handle large, high-resolution pathology images. By reducing the complexity of image data, Concentriq Embeddings allows researchers and developers to create AI models with significantly less time and computational power
2
.Alongside Concentriq Embeddings, Proscia has launched a comprehensive Developer Toolkit. This suite of tools and resources is designed to support pathologists, researchers, and software developers in creating, testing, and deploying AI applications for pathology
1
. The toolkit includes:By providing these resources, Proscia aims to lower the barriers to entry for AI development in pathology and foster innovation in the field
2
.Related Stories
The launch of Concentriq Embeddings and the Developer Toolkit has far-reaching implications for healthcare. These tools have the potential to:
The announcement has been met with enthusiasm from the pathology and AI communities. Experts believe that these tools could significantly reduce the time and resources required to develop and deploy AI applications in pathology
1
. As the adoption of digital pathology continues to grow, Proscia's innovations are expected to play a crucial role in shaping the future of disease diagnosis and treatment.Looking ahead, the company plans to continue refining and expanding its AI development ecosystem, with the goal of making AI-powered pathology more accessible and impactful in healthcare settings worldwide
2
.Summarized by
Navi
[1]
09 Sept 2024

08 Apr 2025•Health

14 Jan 2025•Health

1
Technology

2
Policy and Regulation

3
Technology
